Effectiveness of extrafine sngle inhaler triple therapy in Chronic Obstructive Pulmonary Disease (COPD) in Germany: the TriOptimize study

Changes in HRQoL, COPD specific symptoms, lung function & treatment adherence after six months of treatment with efSITT in patients with moderate-to-severe COPD

Saved in:
Bibliographic Details
Main Authors: Geßner, Christian (Author) , Trinkmann, Frederik (Author) , Javan, Sanaz Bahari (Author) , Hövelmann, Raimund (Author) , Bogoevska, Valentina (Author) , Georges, George (Author) , Nudo, Elena (Author) , Criée, Carl-Peter (Author)
Format: Article (Journal)
Language:English
Published: 2 December 2022
In: The International journal of chronic obstructive pulmonary disease
Year: 2022, Volume: 17, Pages: 3019-3031
ISSN:1178-2005
DOI:10.2147/COPD.S382405
Online Access:Resolving-System, kostenfrei, Volltext: https://doi.org/10.2147/COPD.S382405
Verlag, lizenzpflichtig, Volltext: https://www.dovepress.com/effectiveness-of-extrafine-single-inhaler-triple-therapy-in-chronic-ob-peer-reviewed-fulltext-article-COPD
Get full text
Author Notes:Christian Gessner, Frederik Trinkmann, Sanaz Bahari Javan, Raimund Hövelmann, Valentina Bogoevska, George Georges, Elena Nudo, Carl-Peter Criée
Description
Summary:Changes in HRQoL, COPD specific symptoms, lung function & treatment adherence after six months of treatment with efSITT in patients with moderate-to-severe COPD
Item Description:Gesehen am 10.02.2023
Physical Description:Online Resource
ISSN:1178-2005
DOI:10.2147/COPD.S382405